A Prospective Trial to Evaluate Up-front Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Patients With Advanced Pulmonary Arterial Hypertension (IIR-3810)
Latest Information Update: 25 Feb 2025
At a glance
- Drugs Riociguat (Primary) ; Treprostinil (Primary)
- Indications Pulmonary arterial hypertension
- Focus Pharmacodynamics
- Acronyms IIR-3810
Most Recent Events
- 20 Feb 2025 Planned End Date changed from 1 Dec 2021 to 31 Dec 2025.
- 20 Feb 2025 Planned primary completion date changed from 1 Dec 2020 to 31 Dec 2025.
- 21 Aug 2019 New trial record